Modelling the onset of senescence at the G1/S cell cycle checkpoint

BMC Genomics

Volumn 15, Issue 7, 2014, Pages

  Mombach, José CM ^a,b   Bugs, Cristhian A ^c   Chaouiya, Claudine ^b  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^c UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

Author keywords

Cell cycle checkpoint; Cell fate; DNA damage; Logical modelling; Senescence; Signalling network

Indexed keywords

DNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 14; ATM PROTEIN;

APOPTOSIS; ARTICLE; ATAXIA TELANGIECTASIA; CELL CYCLE ARREST; CELL DEATH; CELL FATE; CELL PROLIFERATION; DNA DAMAGE; DNA REPAIR; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE MUTATION; HUMAN; M PHASE CELL CYCLE CHECKPOINT; S PHASE CELL CYCLE CHECKPOINT; SENESCENCE; BIOLOGICAL MODEL; CELL AGING; GENETICS; METABOLISM; MUTATION; SIGNAL TRANSDUCTION;

APOPTOSIS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL AGING; DNA DAMAGE; DNA REPAIR; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 14; MODELS, BIOLOGICAL; MUTATION; S PHASE CELL CYCLE CHECKPOINTS; SIGNAL TRANSDUCTION;

EID: 84964312969     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-15-S7-S7     Document Type: Article

References (63)

1. Nurse P: A long twentieth century of the cell cycle and beyond. Cell. 2000, 100: 71-78. 10.1016/S0092-8674(00)81684-0.
2. Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K, Linn S: Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem. 2004, 73: 39-85. 10.1146/annurev.biochem.73.011303.073723.
3. Pereira B, Ferreira MG: Sowing the seeds of cancer: telomeres and age-associated tumorigenesis. Curr Opin Oncol. 2013, 25: 93-98.
4. Campisi J: Aging, cellular senescence, and cancer. Annu Rev Physiol. 2013, 75: 685-705. 10.1146/annurev-physiol-030212-183653.
5. Simão ÉM, Sinigaglia M, Bugs CA, Castro MAA, Librelotto GR, Alves R, Mombach JCM: Induced genome maintenance pathways in pre-cancer tissues describe an anti-cancer barrier in tumor development. Molecular BioSystems. 2012, 8: 3003-10.1039/c2mb25242b.
6. Coppé J-P, Rodier F, Patil CK, Freund A, Desprez P-Y, Campisi J: Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. J Biol Chem. 2011, 286: 36396-36403. 10.1074/jbc.M111.257071.
7. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS: The essence of senescence. Genes Dev. 2010, 24: 2463-2479. 10.1101/gad.1971610.
8. Medema RH, Macůrek L: Checkpoint control and cancer. Oncogene. 2012, 31: 2601-2613. 10.1038/onc.2011.451.
9. Zhang X-P, Liu F, Wang W: Two-phase dynamics of p53 in the DNA damage response. Proceedings of the National Academy of Sciences. 2011, 108: 8990-8995. 10.1073/pnas.1100600108.
10. Fisher J, Henzinger TA: Executable cell biology. Nat Biotechnol. 2007, 25: 1239-1249. 10.1038/nbt1356.
11. Barillot E, Calzone L, Hupe P, Vert JP, Zinovyev A: Computational systems biology of cancer. 2013, Chapman and Hall
12. De Jong H: Modeling and simulation of genetic regulatory systems: a literature review. J Comput Biol. 2002, 9: 67-103. 10.1089/10665270252833208.
13. Cheng TMK, Gulati S, Agius R, Bates PA: Understanding cancer mechanisms through network dynamics. Briefings in Functional Genomics. 2012, 11: 543-560. 10.1093/bfgp/els025.
14. Iwamoto K, Hamada H, Eguchi Y, Okamoto M: Mathematical modeling of cell cycle regulation in response to DNA damage: Exploring mechanisms of cell-fate determination. Biosystems. 2011, 103: 384-391. 10.1016/j.biosystems.2010.11.011.
15. Purvis JE, Karhohs KW, Mock C, Batchelor E, Loewer A, Lahav G: p53 dynamics control cell fate. Science. 2012, 336: 1440-1444. 10.1126/science.1218351.
16. Fauré A, Thieffry D: Logical modelling of cell cycle control in eukaryotes: a comparative study. Mol Biosyst. 2009, 5: 1569-1581. 10.1039/b907562n.
17. Schlatter R, Schmich K, Avalos Vizcarra I, Scheurich P, Sauter T, Borner C, Ederer M, Merfort I, Sawodny O: ON/OFF and beyond--a boolean model of apoptosis. PLoS Comput Biol. 2009, 5: e1000595-10.1371/journal.pcbi.1000595.
18. Poltz R, Naumann M: Dynamics of p53 and NF-ΚB regulation in response to DNA damage and identification of target proteins suitable for therapeutic intervention. BMC Syst Biol. 2012, 6: 125-10.1186/1752-0509-6-125.
19. Calzone L, Tournier L, Fourquet S, Thieffry D, Zhivotovsky B, Barillot E, Zinovyev A: Mathematical modelling of cell-fate decision in response to death receptor engagement. PLoS Comput Biol. 2010, 6: e1000702-10.1371/journal.pcbi.1000702.
20. Grieco L, Calzone L, Bernard-Pierrot I, Radvanyi F, Kahn-Perls B, Thieffry D: Integrative Modelling of the Influence of MAPK Network on Cancer Cell Fate Decision. PLoS Computational Biology. 2013, 9: e1003286-10.1371/journal.pcbi.1003286.
21. Lanigan F, Geraghty JG, Bracken AP: Transcriptional regulation of cellular senescence. Oncogene. 2011, 30: 2901-2911. 10.1038/onc.2011.34.
22. Abraham RT: Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes & Development. 2001, 15: 2177-2196. 10.1101/gad.914401.
23. D' Adda di Fagagna F: Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer. 2008, 8: 512-522. 10.1038/nrc2440.
24. Haupt S, Berger M, Goldberg Z, Haupt Y: Apoptosis - the p53 network. J Cell Sci. 2003, 116: 4077-4085. 10.1242/jcs.00739.
25. Reinhardt HC, Yaffe MB: Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr Opin Cell Biol. 2009, 21: 245-255. 10.1016/j.ceb.2009.01.018.
26. Kracikova M, Akiri G, George A, Sachidanandam R, Aaronson SA: A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis. Cell Death Differ. 2013, 20: 576-588. 10.1038/cdd.2012.155.
27. Stott FJ: The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2. The EMBO Journal. 1998, 17: 5001-5014. 10.1093/emboj/17.17.5001.
28. Bulavin DV, Phillips C, Nannenga B, Timofeev O, Donehower LA, Anderson CW, Appella E, Fornace AJ: Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16Ink4a-p19Arf pathway. Nature Genetics. 2004, 36: 343-350. 10.1038/ng1317.
29. Ito K, Hirao A, Arai F, Takubo K, Matsuoka S, Miyamoto K, Ohmura M, Naka K, Hosokawa K, Ikeda Y, Suda T: Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nature Medicine. 2006, 12: 446-451. 10.1038/nm1388.
30. Thornton TM: Non-Classical P38 Map Kinase Functions: Cell Cycle Checkpoints and Survival. International Journal of Biological Sciences. 2009, 44-52.
31. Lafarga V, Cuadrado A, Lopez de Silanes I, Bengoechea R, Fernandez-Capetillo O, Nebreda AR: p38 Mitogen-Activated Protein Kinase- and HuR-Dependent Stabilization of p21Cip1 mRNA Mediates the G1/S Checkpoint. Molecular and Cellular Biology. 2009, 29: 4341-4351. 10.1128/MCB.00210-09.
32. Toledo LI, Murga M, Gutierrez-Martinez P, Soria R, Fernandez-Capetillo O: ATR signaling can drive cells into senescence in the absence of DNA breaks. Genes Dev. 2008, 22: 297-302. 10.1101/gad.452308.
33. Jenkins NC, Liu T, Cassidy P, Leachman SA, Boucher KM, Goodson AG, Samadashwily G, Grossman D: The p16INK4A tumor suppressor regulates cellular oxidative stress. Oncogene. 2010, 30: 265-274.
34. Sørensen CS, Syljuåsen RG, Falck J, Schroeder T, Rönnstrand L, Khanna KK, Zhou B-B, Bartek J, Lukas J: Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell. 2003, 3: 247-258. 10.1016/S1535-6108(03)00048-5.
35. Porras A, Zuluaga S, Black E, Valladares A, Alvarez AM, Ambrosino C, Benito M, Nebreda AR: P38 alpha mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol Biol Cell. 2004, 15: 922-933.
36. Wang W, Chen JX, Liao R, Deng Q, Zhou JJ, Huang S, Sun P: Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol Cell Biol. 2002, 22: 3389-3403. 10.1128/MCB.22.10.3389-3403.2002.
37. Niida H, Murata K, Shimada M, Ogawa K, Ohta K, Suzuki K, Fujigaki H, Khaw AK, Banerjee B, Hande MP, Miyamoto T, Miyoshi I, Shirai T, Motoyama N, Delhase M, Appella E, Nakanishi M: Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo. EMBO J. 2010, 29: 3558-3570. 10.1038/emboj.2010.218.
38. Hewitt G, Jurk D, Marques FDM, Correia-Melo C, Hardy T, Gackowska A, Anderson R, Taschuk M, Mann J, Passos JF: Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nature Communications. 2012, 3: 708-
39. Buscemi G, Carlessi L, Zannini L, Lisanti S, Fontanella E, Canevari S, Delia D: DNA damage-induced cell cycle regulation and function of novel Chk2 phosphoresidues. Mol Cell Biol. 2006, 26: 7832-7845. 10.1128/MCB.00534-06.
40. Chen C-R, Wang W, Rogoff HA, Li X, Mang W, Li CJ: Dual induction of apoptosis and senescence in cancer cells by Chk2 activation: checkpoint activation as a strategy against cancer. Cancer Res. 2005, 65: 6017-6021. 10.1158/0008-5472.CAN-05-0677.
41. Zhan H, Suzuki T, Aizawa K, Miyagawa K, Nagai R: Ataxia telangiectasia mutated (ATM)-mediated DNA damage response in oxidative stress-induced vascular endothelial cell senescence. J Biol Chem. 2010, 285: 29662-29670. 10.1074/jbc.M110.125138.
42. Sørensen CS, Hansen LT, Dziegielewski J, Syljuåsen RG, Lundin C, Bartek J, Helleday T: The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nature Cell Biology. 2005, 7: 195-201. 10.1038/ncb1212.
43. Hemmati PG, Gillissen B, von Haefen C, Wendt J, Stärck L, Güner D, Dörken B, Daniel PT: Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis. Oncogene. 2002, 21: 3149-3161. 10.1038/sj.onc.1205458.
44. Wade M, Wang YV, Wahl GM: The p53 orchestra: Mdm2 and Mdmx set the tone. Trends in Cell Biology. 2010, 20: 299-309. 10.1016/j.tcb.2010.01.009.
45. De Oca Luna RM, Wagner DS, Lozano G: Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature. 1995, 378: 203-206. 10.1038/378203a0.
46. Urashima M, Teoh G, Chauhan D, Ogata A, Shirahama S, Kaihara C, Matsuzaki M, Matsushima H, Akiyama M, Yuza Y, Maekawa K, Anderson KC: MDM2 protein overexpression inhibits apoptosis of TF-1 granulocyte-macrophage colony-stimulating factor-dependent acute myeloblastic leukemia cells. Blood. 1998, 92: 959-967.
47. Hemmati PG, Normand G, Verdoodt B, von Haefen C, Hasenjäger A, Güner D, Wendt J, Dörken B, Daniel PT: Loss of p21 disrupts p14 ARF-induced G1 cell cycle arrest but augments p14 ARF-induced apoptosis in human carcinoma cells. Oncogene. 2005, 24: 4114-4128. 10.1038/sj.onc.1208579.
48. Taneja P, Zhu S, Maglic D, Fry EA, Kendig RD, Inoue K: Transgenic and knockout mice models to reveal the functions of tumor suppressor genes. Clin Med Insights Oncol. 2011, 5: 235-257.
49. Ray D, Kiyokawa H: CDC25A Phosphatase: a Rate-Limiting Oncogene That Determines Genomic Stability. Cancer Research. 2008, 68: 1251-1253. 10.1158/0008-5472.CAN-07-5983.
50. Yap DB, Hsieh JK, Chan FS, Lu X: mdm2: a bridge over the two tumour suppressors, p53 and Rb. Oncogene. 1999, 18: 7681-7689. 10.1038/sj.onc.1202954.
51. Van den Heuvel S, Dyson NJ: Conserved functions of the pRB and E2F families. Nat Rev Mol Cell Biol. 2008, 9: 713-724. 10.1038/nrm2469.
52. Chaouiya C, Naldi A, Thieffry D: Logical modelling of gene regulatory networks with GINsim. Methods Mol Biol. 2012, 804: 463-479. 10.1007/978-1-61779-361-5_23.
53. Comet J-P, Noual M, Richard A, Aracena J, Calzone L, Demongeot J, Kaufman M, Naldi A, Snoussi EH, Thieffry D: On circuit functionality in boolean networks. Bull Math Biol. 2013, 75: 906-919. 10.1007/s11538-013-9829-2.
54. Thieffry D: Dynamical roles of biological regulatory circuits. Briefings in Bioinformatics. 2007, 8: 220-225. 10.1093/bib/bbm028.
55. Abou-Jaoudé W, Ouattara DA, Kaufman M: From structure to dynamics: frequency tuning in the p53-Mdm2 network I. Logical approach. J Theor Biol. 2009, 258: 561-77. 10.1016/j.jtbi.2009.02.005.
56. Thomas R: On the Relation Between the Logical Structure of Systems and Their Ability to Generate Multiple Steady States or Sustained Oscillations. Numerical Methods in the Study of Critical Phenomena. Edited by: Dora J, Demongeot J, Lacolle B Berlin, Heidelberg. 1981, Springer Berlin Heidelberg, 9: 180-193. 10.1007/978-3-642-81703-8_24.
57. Thomas R, D'Ari R: Biological Feedback. 1990, CRC Press
58. Thomas R, Thieffry D, Kaufman M: Dynamical behaviour of biological regulatory networks-I. Biological role of feedback loops and practical use of the concept of the loop-characteristic state. Bull Math Biol. 1995, 57: 247-76. 10.1007/BF02460618.
59. Chaouiya C, Remy É, Mossé B, Thieffry D: Qualitative Analysis of Regulatory Graphs: A Computational Tool Based on a Discrete Formal Framework. Lecture Notes in Control and Information Sciences. 2003, 294: 119-126. [ http://dx.doi.org/10.1007/b79667 ]
60. Fauré A, Naldi A, Chaouiya C, Thieffry D: Dynamical analysis of a generic Boolean model for the control of the mammalian cell cycle. Bioinformatics. 2006, 22: e124-31. 10.1093/bioinformatics/btl210.
61. Naldi A, Berenguier D, Fauré A, Lopez F, Thieffry D, Chaouiya C: Logical modelling of regulatory networks with GINsim 2.3. BioSystems. 2009, 97: 134-139. 10.1016/j.biosystems.2009.04.008.
62. Naldi A, Thieffry D, Chaouiya C: Decision Diagrams for the Representation and Analysis of Logical Models of Genetic Networks. Lecture Notes in Computer Science. 2007, 4695: 233-247. 10.1007/978-3-540-75140-3_16.
63. Remy E, Ruet P: From minimal signed circuits to the dynamics of Boolean regulatory networks. Bioinformatics. 2008, 24: i220-226. 10.1093/bioinformatics/btn287.